Recursion Pharmaceuticals (RXRX) Common Equity (2020 - 2026)
Recursion Pharmaceuticals (RXRX) posted Common Equity of $915 million for Q2 2026, down 0.5% from $919.15 million a year earlier and down 10.7% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Recursion Pharmaceuticals' Common Equity came in at $1.13 billion, up 9.3% from FY2024.
- In prior years, Recursion Pharmaceuticals' Common Equity was $1.03 billion in FY2024 (+123.3%), $463.44 million in FY2023 (-4.6%), $485.81 million in FY2022 (-10.5%) and $542.94 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Common Equity since Q3 2024.
- On a year-over-year basis, Common Equity increased in seven of the last eight quarters, with growth averaging 56.4%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q1 2025, with growth of 132.8%; the weakest was Q3 2022, with a decline of 35.2%.
- According to Business Quant data, Common Equity for the three prior quarters was $1.02 billion (Q1 2026), $1.13 billion (Q4 2025) and $1.05 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn | 915.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 915.00 Mn |
| Mar 31, 2026 | 1.02 Bn |
| Dec 31, 2025 | 1.13 Bn |
| Sep 30, 2025 | 1.05 Bn |
| Jun 30, 2025 | 919.15 Mn |
| Mar 31, 2025 | 933.95 Mn |
| Dec 31, 2024 | 1.03 Bn |
| Sep 30, 2024 | 524.56 Mn |
| Jun 30, 2024 | 584.45 Mn |
| Mar 31, 2024 | 401.15 Mn |
| Dec 31, 2023 | 463.44 Mn |
| Sep 30, 2023 | 437.97 Mn |
| Jun 30, 2023 | 468.96 Mn |
| Mar 31, 2023 | 430.18 Mn |
| Dec 31, 2022 | 485.81 Mn |
| Sep 30, 2022 | 388.03 Mn |
| Jun 30, 2022 | 437.58 Mn |
| Mar 31, 2022 | 493.57 Mn |
| Dec 31, 2021 | 542.94 Mn |
| Sep 30, 2021 | 599.03 Mn |
API Access
Recursion Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();